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ABSTRACT
Background & objectives: Crimean-Congo hemorrhagic fever is an acute viral hemorrhagic fever with
considerable mortality. Despite increasing knowledge about hemorrhagic fever viruses, the pathogenesis of
Crimean-Congo hemorrhagic fever and causes of death were not well described.  We aimed to evaluate whether
there were electrocardiographic parameters designating mortality among these patients.
Study design: This retrospective study was performed among confirmed Crimean-Congo hemorrhagic fever
cases in Turkey. Electrocardiography was available in 49 patients within 24 h of hospitalization. All
electrocardiograms were evaluated by two expert cardiologists according to Minnesota coding system.
Results: Among patients with available electrocardiograms, there were 31 patients who survived, and 18
patients who died of Crimean-Congo hemorrhagic fever. Both groups were similar in terms of age, sex, body
temperature, heart rate,  and blood parameters. T-wave changes and bundle branch block were more frequently
encountered among those who died. Presence of T-wave negativity or bundle branch block in this cohort of
patients with Crimean-Congo hemorrhagic fever predicted death with a sensitivity of 72.7%, specificity of
92.6%, positive predictive value of 88.9%, negative predictive value of 80.6%.
Conclusions: We think within the light of our findings that simple electrocardiography at admission may help
risk stratification among Crimean-Congo hemorrhagic fever cases.
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INTRODUCTION
Crimean-Congo hemorrhagic fever (CCHF) is an acute
viral hemorrhagic fever with 10–30% of case fatality rate.
CCHF virus within the genus Nairovirus of the family
Bunyaviridae is responsible for the clinical picture. CCHF
was first described in the 1940s, and is now endemic in
different regions of Africa, Asia, and eastern Europe.  Hu-
man becomes infected through tick bites, by crushing in-
fected ticks, after contact with a patient with CCHF dur-
ing the acute phase of infection, or by contact with blood
or tissues from viraemic livestock. The most important
clinical features are fever and in most severe cases, shock
and hemorrhage. Despite, enormous amount of knowledge
coming recently, causes of death are still not well-de-
scribed1,2.  It has been reported that mononuclear phago-
cytes, hepatocytes and endothelial cells are major targets
of CCHF virus infection3. However, to our knowledge,
still inadequate data are available on the cellular targets
and distribution of CCHF virus in human tissues.
Refractory shock, severe coagulopathy and multifo-
cal necrosis of the liver and other viscera are the modes of
death4. Our group has recently demonstrated some
echocardiographic findings associated with cardiac in-
volvement among CCHF cases. However, electrocardio-
graphy (ECG) was not evaluated among these cases pre-
viously in literature. In this study, we aimed to show
whether ECG, obtained in the hospital course of CCHF
patients might help predict outcomes, mainly mortality,
or not.
MATERIAL & METHODS
Study design
A total of 375, patients with suspicion of CCHF were
admitted to the hospital betweeen 2007–08. Diagnosis was
confirmed in 316 patients, 12-lead ECG recorded within
24 h of admission was available in 49 patients. All pa-
tients, who had confirmed diagnosis of CCHF and avail-
able ECG were enrolled retrospectively into our study.
Electrocardiograms were manually evaluated by the use
of a magnifying glass by two expert cardiologists (GB-
MRE), blinded to patients’ information and blinded to each
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obtained from another expert. Electrocardiographic find-
ings were classified according to Minnesota code classifi-
cation system. Abnormalities, noted in patients ECGs’ were
as follows: ST depression (Minnesota code 4.1.2: STJ
depression > 1 mm but < 2 mm and ST segment horizon-
tal or downward sloping in any of leads V1, V2, V3, V4,
V5), T-wave changes (Minnesota code 5.2: T amplitude
negative or diphasic with negative phase at least 1 mm but
not as deep as 5 mm in lead I or V6, or in lead aVL when
R amplitude is > 5 mm), early QRS transition zone (Min-
nesota code 9.4.1: QRS transition zone at V3 or to the
right of V3 on the chest),  complete right bundle branch
block (RBBB) (Minnesota code 7.2.1),  complete left
bundle branch block (LBBB) (Minnesota code 7.1.1).
PR interval, QRS duration, QT interval and P-wave
intervals were evaluated thoroughly. Normal QRS axis
was accepted to be between –110 and +30 degrees. Ab-
normalities of the rhythm other than sinus were searched
carefully. Left and right ventricular hypertrophy were
searched accordingly5,6. Presence of any supraventricular
or ventricular beat was evaluated.
QT intervals were taken from the onset of the QRS
complex to the end of the T-wave, which was defined as
the point T-wave returned to TP baseline7. R-R interval
was used to compute heart rate in order to calculate cor-
rected QT interval (QTc) with Bazett’s formula.
The onset of the P-wave was defined as the junction
between the isoelectric line at the beginning of the P-wave
deflection and the offset of the P-wave was defined as the
junction between the end of the P-wave and the isoelectric
line. Maximum and minimum P-wave durations were mea-
sured, and then P-wave dispersion (defined as the differ-
ence between P-maximum and P-minimum) was calculated8.
The definitive diagnosis of CCHF infection was based
upon typical clinical and epidemiological findings and
detection of CCHF virus-specific IgM by ELISA or of
genomic segments of the CCHF virus by reverse transcrip-
tion-polymerase chain reaction (RT-PCR) either in the
acute and convalescent phase of the disease.
Statistical analysis
Demographics and ECG findings were recorded for
each patient.  Parametric data were expressed as mean ±
SD or median (range) as required and categorical data as
percentages. Independent parameters were compared by
Mann-Whitney U-test. Proportions for categorical vari-
ables were compared using the Chi-square test, although
Fisher’s exact test was used when the data were sparse. A
p < 0.05 was accepted significant, using two-sided com-
parisons. SPSS (version 10.0) was used to perform statis-
tical procedures.
RESULTS
Age, sex, platelet count, white blood cell count, body
temperature and electrolyte levels were similar between
groups  (Table 1). There was no case with ST elevation
and supraventricular or ventricular beat. None of the pa-
tients had electrolyte abnormality which could bring about
ECG abnormality, during ECG recording. None of the
patients had rhythm abnormality. All were in sinus rhythm.
Patients in both groups were not different from each other
concerning ST shift, QRS axis, heart rate, PR intervals,
QRS duration, QT intervals and P intervals (Table 1). Of
note, no patient had left or right ventricular hypertrophy
signs. Furthermore, none was on digoxin therapy. There
was complete agreement between two blinded experts who
coded ECGs. Among patients who died of CCHF, early
QRS transition zone, T-wave changes, LBBB  or RBBB
were more frequently encountered compared to those who
survived CCHF (Table 1).
Presence of T-wave changes or bundle branch block
(LBBB or RBBB) in this cohort of patients with CCHF
predicted death with a sensitivity of 72.7%, specificity of
92.6%, positive predictive value of 88.9%, and negative
predictive value of 80.6%. Presence of  T-wave changes
or bundle branch block (LBBB or RBBB) was associated
with 33.333 fold (Odds ratio, 95% confidence interval
5.975–185.952) increased risk of death.
The ECG parameters with significance in the
univariate analysis were enrolled into multivariable logis-
tic regression analysis. It was found that T-wave changes
(in the absence of LBBB or RBBB) (p=0.003,
ExpB=17.668, 95% confidence interval 2.737–114.061),
and presence of complete bundle branch block (mainly
RBBB) (p=0.007, ExpB=39.882, 95% confidence inter-
val 2.744–579.669) were found to be electrocardiographic
independent predictors of death among patients with
CCHF.
DISCUSSION
It has previously been  demonstrated that hemorrhagic
fever viruses could also cause cardiac involvement either
in experimental or clinical studies. Histologic myocardial
lesions, including focal lymphoblastic infiltrates, vascu-
lar ruptures, and mild interstitial reactive change demon-
strating cardiac involvement have been observed in ex-
perimental Junin virus infected monkeys9. Dengue virus
and yellow fever virus, the members of the flavivirus fam-
ily can also cause cardiac involvement in humans10-13. A
histopathological study by Burt et al3 showed congestion
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case. The observation of cardiac congestion and edema in
that fatal CCHF case may support cardiac involvement in
CCHF infection. However, little is known about the effect
of CCHF virus on the heart. We have recently shown that
CCHF might involve cardiac structures as demonstrated
by echocardiography14. However, so far, electrocardio-
graphy has never been considered in detail among these
patients. Many viral diseases might induce ECG changes
through involvement of cardiac tissues, which might re-
spond via surface ECG abnormalities usually in mild
forms.
It has been reported that certain ECG abnormalities
associated with fatal outcome and/or clinical severity of
some disease states. Bethell et al15 studied electrocardio-
graphic findings of patients with severe diphtheria and
found the degree of ventricular ectopy at the time of pre-
sentation significantly associated with fatal outcome. In
that study, more than two ventricular ectopic beats on a
recording upon admission to the hospital predicted fatal
outcome with 100% sensitivity and cent percent specific-
ity. Salles et al16 reported that electrocardiographic QT-
interval dispersion (QTd) and echocardiographic LV end-
systolic dimension were the most important mortality
predictors in patients with Chagas’ disease. That study
demonstrated that both ECG ventricular repolarization
parameters, QTcmax interval duration and QT interval
dispersion, were important mortality risk predictors in
patients with Chagas’ disease. In this study, QT param-
eters were not different between those who died and those
who survived of CCHF. None was found to have ectopic
beats in the ECG recordings. However, presence of T-
wave negativity and bundle branch block were associated
with mortality.
In an experimental study, the electrocardiographic
changes following rabbit coronavirus infection were ex-
amined. However, in that study, there were no significant
Table 1. Comparison of demographics and electrocardiographic findings of Crimean-Congo hemorrhagic fever (CCHF)
patients who survived versus who died
Variable Patients who died  (n=18) Patients who survived (n=31) P-value
Age (yr) 48.2 ± 21 48.6 ± 19.7 0.969
Sex (Male/female) 9/9 18/13 0.803
Heart rate (Beats per minute) 85 ± 18 81 ± 21 0.425
Body temperature (oC) 37.2 ± 1.1 37.4 ± 0.9 0.636
WBC count (per mm3) 5.9 ± 6.2 3.4 ± 2.5 0.117
Platelet count (per mm3) 36.5 ± 40.1 61.5 ± 45.1 0.05
Sodium (mEq/L) 135.6 ± 5.3 135.8 ± 2.8 0.841
Potassium (mEq/L) 4.2 ± 0.8 4.0 ± 0.5 0.258
PR interval (msec) 13.9 ± 2.5 15.2 ± 3.3 0.185
QRS duration (msec) 8.9 ± 1.9 8 ± 2.1 0.142
ST depression 3/18 4/31 0.697
Presence of normal QRS axis 15/18 25/31 0.815
QTcmax (msec) 417.2 ± 14.9 416.7 ± 12.6 0.903
QTc dispersion (msec) 28 ± 6.5 28 ± 7.2 1
Pmax (msec) 98 ± 10.6 99.3 ± 8.9 0.657
P-wave dispersion (msec) 30.8 ± 4.6 31.1 ± 5.6 0.823
Early QRS transition zone* 15/18 10/31 0.002
ST depression in V1–5 3/18 4/31 0.697
ST depression in V1–5 in the absence of LBBB or 1/18 2/31 1
   RBBB (compatible with coding)
T-wave changes 14/18 6/31 <0.001
T-wave changes in the absence of LBBB or RBBB 9/18 5/31 0.02
   (compatible with coding)*
Presence of LBBB or RBBB* 7/18 1/31 0.002
Persence of LBBB, RBBB or T-wave changes 16/18 6/31 <0.001
Presence of early QRS transition zone or RBBB or LBBB 15/18 10/31 0.001
Presence of ST depression or LBBB or RBBB 8/18 6/31 0.122
Presence of ST depression or, T-wave changes or 16/18 9/31 <0.001
   LBBB or RBBB
*Parameters enrolled into logistic regression, for Minnesota codes, please refer to manuscript; LBBB: Left bundle branch block; RBBB: Right
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differences identified between ECG parameters measured
in animals dying in the acute phase and those animals sur-
viving into the subacute and chronic phases17.
In the literature, we found several studies related to
electrocardiographic findings of other viral hemorrhagic
fever virus infections such as Lassa fever,  dengue, and
Hantavirus infections18-24. Cummins et al18 found elec-
trocardiographic abnormalities such as non-specific ST-
segment and T-wave abnormalities, ST-segment elevation
in patients with Lassa fever. In their study, none of the
abnormalities correlated with clinical severity of infection.
Electrocardiographic abnormalities as a result of dengue
infection are common and have been reported to be in the
range of 34–75%19. These are predominantly sinus brady-
cardia and conduction defects, all of which are transient.
Hantavirus belonging to the Bunyaviridae family, the same
family as that of the CCHF virus, causes haemorrhagic
fever with renal syndrome (HFRS) is a systemic infec-
tious disease.
Earlier reports describe different abnormal ECG find-
ings during hantavirus infection. Basin et al20  report on
AV block in 2 patients with HFRS. Kim et al21 described
a case of torsade de pointes associated with hypopituitar-
ism due to HFRS. In an another study, transient disap-
pearance of hyperthyroidism with atrial fibrillation dur-
ing the course of HFRS is described22. Kapetanoviae et
al23 found ECG alterations in 39 out of 43 patients with
HFRS, mostly in the oliguric stage. The predominant find-
ing was prolonged QT interval, followed by a tall and
peaked T-wave. The authors concluded a tall and peaked
T-wave and bradycardia in the oliguric stage to be pathog-
nomonic of HFRS. Puljiz et al24 also reported electrocar-
diographic changes in patients with HFRS. In their study,
abnormal ECG was found in more than one-third of HFRS
patients with the most common findings during the oliguric
stage. Puljiz et al. determined ECG disorder such as sinus
tachycardia or bradycardia, bundle branch conduction
defects, non-specific ventricular repolarization distur-
bances, supraventricular and ventricular extrasystoles,
prolonged QT interval, low voltage of the QRS complexes
in standard limb leads, atrioventricular block first-degree,
and atrial fibrillation in patients with HFRS.
There has been no study investigating electrocardio-
graphic findings of patients with CCHF. In our study,
mortal cases demonstrated variable degrees of ECG ab-
normalities. Particularly, T-wave changes and bundle
branch blocks were noted to designate mortality. Of note,
only one patient had left bundle branch block, and that
patient survived, whereas 7 out of 7 patients with right
bundle branch block died.
There are several reservations of the current study
worthwhile mentioning. First of all, ECG is not part of a
routine practice in follow up of cases with CCHF, and
hence, ECG was present in a small group of patients with
more severe disease. That was the reason for such high
mortality, which is not the case in the overall population
of cases with CCHF, in the cohort. Of note, this study
was not performed to show mortality rate of CCHF, and
hence, could give pieces of information for those patients
who were referred to ECG. Therefore, findings should not
be generalized to milder cases with CCHF. Furthermore,
ECG findings are not specific for CCHF cases, and hence,
could be observed in several other disease states. How-
ever, they are relatively easy to notice, and hence may
help risk stratification  particularly in the presence of
baseline ECG, obtained at admission for comparison. It
could have been better to incorporate cardiac biomarkers
and other imaging modalities in order to show the timing
and extent of any cardiac involvement in CCHF and to
associate it with ECG findings. Besides, we did not have
previous ECGs available though we did have the knowl-
edge that no patient had previous history of heart disease.
However, we think that ECG, as a potential marker of
severity, might be part of follow-up of patients with CCHF,
and physicians should be encouraged to obtain ECG
samples both at admission and during follow up of these
patients.
In conclusion, in this pioneering study, it seems that
there are subtle ECG abnormalities among those who died
up on CCHF infection compared to those who survived.
Hence, at least among relatively severe patients, it might
be important to obtain one ECG sample, which is easy
and cheap, at admission to the hospital.
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